These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Spontaneous calcaneal fracture in osteoporosis without fluoride therapy. Verlooy H, Westhovens R, Mortelmans L, De Roo M. Clin Nucl Med; 1991 Nov; 16(11):867-8. PubMed ID: 1752102 [No Abstract] [Full Text] [Related]
3. [Treatment of postmenopausal with sodium fluoride. Effect on mineral bone content of the radius]. de Guembecker W, Duriez J, de Guembecker C. Rev Rhum Mal Osteoartic; 1989 May; 56(6):499-503. PubMed ID: 2740812 [No Abstract] [Full Text] [Related]
4. The value of local 99mTc(Sn)-MDP bone to soft tissue uptake ratio in osteoporosis, before and during fluoride therapy. Raymakers JA, Savelkoul TJ, Hoekstra A, Visser WJ, van Rijk PP, Duursma SA. Eur J Nucl Med; 1990 May; 16(3):157-60. PubMed ID: 2364958 [Abstract] [Full Text] [Related]
10. The use of technetium Tc 99m medronate scintigraphy as a prognostic guide in childhood dermatomyositis. Guillet J, Blanquet P, Guillet G, Mollard S, Massicot P, Maleville J. Arch Dermatol; 1981 Aug; 117(8):451. PubMed ID: 6455094 [No Abstract] [Full Text] [Related]
11. New doubts about benefits of sodium fluoride. Skolnick A. JAMA; 1990 Apr 04; 263(13):1752-3. PubMed ID: 2179588 [No Abstract] [Full Text] [Related]
12. Relative lesion detection ability of Tc-99m HMDP and Tc-99m MDP: concise communication. Van Duzee BF, Schaefer JA, Ball JD, Chilton HM, Cowan RJ, Kuni C, Trow R, Watson NE. J Nucl Med; 1984 Feb 04; 25(2):166-9. PubMed ID: 6233404 [Abstract] [Full Text] [Related]
13. [Transient osteoporosis of the hip joint]. Möttönen T, Hannonen P, Oka M. Duodecim; 1986 Feb 04; 102(13):891-4. PubMed ID: 3757832 [No Abstract] [Full Text] [Related]
14. [Whole body bone scintigram with 99mTc-HMDP (technetium-99m-hydroxy methylene diphosphonate) (author's transl)]. Isobe Y, Ko S, Umegaki Y, Takahashi S, Kawaguchi N, Wada S, Matsumoto S. Radioisotopes; 1981 Nov 04; 30(11):606-8. PubMed ID: 7335900 [No Abstract] [Full Text] [Related]
18. [An evaluation of 99mTc-hydroxymethylene diphosphonate (99mTc-HMDP) as a new bone scanning agent (author's transl)]. Hayashi M, Takahashi K, Furukawa K, Hazue M, Shibatsuji H, Yasuda N, Tanaka K, Yoshikawa I, Maeda K, Hamada S. Radioisotopes; 1981 Jan 04; 30(1):38-9. PubMed ID: 7268059 [No Abstract] [Full Text] [Related]
19. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model. Bevan JA, Tofe AJ, Benedict JJ, Francis MD, Barnett BL. J Nucl Med; 1980 Oct 04; 21(10):967-70. PubMed ID: 6252299 [Abstract] [Full Text] [Related]
20. [Sodium fluoride loading test and the monitoring of fluoride levels in the urine during the treatment of osteoporosis with sodium fluoride]. Pantůcek MB, Karpas K. Acta Chir Orthop Traumatol Cech; 1983 Oct 04; 50(5):476-81. PubMed ID: 6659832 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]